The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis

The value of immune checkpoint inhibitor (ICI) combination therapy for patients with lung cancer remains unclear. We conducted a meta-analysis using PubMed, Embase, and ClinicalTrials.gov databases to identify eligible randomized controlled trials (RCTs) that might provide a reference for clinical p...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Min, Li, Xing, Lei, Gu, Weng, Yi Ming, Hu, Meng Xue, Song, Qi Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204847/
https://www.ncbi.nlm.nih.gov/pubmed/30425525
http://dx.doi.org/10.2147/OTT.S177318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204847/
https://www.ncbi.nlm.nih.gov/pubmed/30425525
http://dx.doi.org/10.2147/OTT.S177318

Ejemplares similares